Lymphatic filariasis
Dr. Suman Saurabh
Associate Professor, Department of
Community and Family Medicine
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Organisms and vectors
Disease Causative organism Vector
Malaria Protozoal parasite:
P. vivax
P. falciparum
Mosquito anopheles
Lymphatic filariasis Nematode:
Wuchereria bancrofti
Brugia malayi
Mosquito
Culex species (mainly
Culex quinquefasciatus)
Kala-azar Protozoal parasite:
Leishmania donovani
Sandfly (Phlebotomus
Argentipes)
Dengue Dengue virus (4 serotypes) Aedes aegypti mosquito
Chikungunya Chikungunya virus Aedes aegypti mosquito
Japanese encephalitis JE virus Culex species (mainly
Culex tritaeniorhynchus)
Malaria
An. culicifacies, An. fluviatilis, An.
minimus
An. sundaicus, An. stephensi, An. dirus
Dengue
Ae. Aegypti, Ae. Albopictus
Filariasis
Cx. quinquefasciatus, Ma. annulifera
and uniformis
Japanese Encephalistis
Cx. vishnui, Cx. tritaeniorhyncus etc.
Kala azar--- Sand fly
Disease Vector species in India
Malaria ,Kala-azar and Filaria in Elimination
mode
National programme
• The malaria control programme
• Lymphatic Filariasis
• Kala-azar
• Japanese Encephalitis
• Dengue
• Chikungunya
Integrated under National Vector Borne Disease
Control Programme (NVBDCP) in Year 2002
Lymphatic filariasis17102023 for MBBS students.pptx
GLOBAL BURDEN OF LF
• Population at risk : 1.23 Billion
• No. of countries: 73
• Hydrocele : 25 Million
• Lymphoedema : 15 Million
Lymphatic filariasis17102023 for MBBS students.pptx
NATIONAL BURDEN OF LF
RAJASTHAN
ORISSA
GUJARAT
MAHARASHTRA
MADHYA PRADESH
BIHAR
KARNATAKA
UTTAR PRADESH
JAMMU & KASHMIR
ASSAM
TAMIL NADU
TELANGANA
CHHATTISGARH
ANDHRA PRADESH
PUNJAB
JHARKHAND
WEST BENGAL
ARUNACHAL PR.
HARYANA
KERALA
UTTARAKHAND
HIMACHAL PRADESH
MANIPUR
MIZORAM
MEGHALAYA
NAGALAND
SIKKIM
GOA
A&N ISLANDS
D&N HAVELI
PONDICHERRY
LAKSHADWEEP
TRIPURA
DELHI
CHANDIGARH
DAMAN & DIU
N
E
W
S
Endemic
Non-Endemic
Uncertain
21 states/UTs
257 districts
650 millions
Hydrocele- 0.38 million
Lymphoedema-0.84 million
Economic Impact of LF
• Globally >2 billion USD lost per year
• Approx. 5 million DALYs lost annually
• Direct costs
– ‘Out-of-pocket’ payments for care
– Costs to health system
• Indirect costs
– Lost productivity (↓30%)
– Social and Psychological impact
LIFE CYCLE OF FILARIAL PARASITE
Video courtesy District vector control unit, Kerala
Photo courtesy District vector control unit, Kerala
The parasite
• Three parasites causing human filariasis: W. bancrofti
B. malayi
B. timori
• In India W. bancrofti and B.malayi
• W. bancrofti – Vector: Culex quinquefasciatus (Breeds in polluted water)
- Contributes 99.4% LF in India
- Distribution both urban & rural
• B.malayi - Seven states – Kerala, Orissa, Tamil Nadu ( Rural areas)
AP, MP, Assam, West Bengal in pockets
- Vector: Mansonia sp (Breeding associated with aquatic plants, viz Pistia)
Filariasis vectors and their breeding spots
Culex quinquefasciatus Mansonia annulifera
Culex quinquefasciatus breeding spot Mansonia breeding places in Pistia plants
Natural History of Lymphatic Filariasis
Un infected individuals
Disease free microfilarial carrier state
Acute disease manifestation
Patients with chronic pathology
Lymphatic Filariasis
Disease Manifestation
Asymptomatic Symptomatic
Acute
• Adenolymphangitis
• Acute epididymo-
orchitis
• funiculitis
Chronic
• Lymphoedema
• Hydrocele
• Elephantiasis
• Chyluria
Clinical spectrum
• Man-Natural host.
• All ages and genders- susceptible to infection
- Youngest age recorded with infection – 6 months
- Peak age of infection= 20 – 25 yrs.
• While infection occurs in child hood diseases
manifests later.
• Disease spectrum:
– Endemic normal
– Asymptomatic micro filarimia
● Sub clinical lymphatic pathology .
– Acute manifestation
– Chronic disease
– Occult clinical manifestation
» Tropical pulmonary Eosinophilia
Acute manifestation
Acute Filarial lymphangitis (AFL):
• Characterised by presence of dilated,
inflammed and thickened lymphatic
vessels associated with erythema,
oedema,tenderness and pain.
• Cause: Parturition of adult, release of
diffusible toxin or death of adult worm.
Dermato lymphangio adenitis (ADLA)
* Entry lesion-Reticular
lymphangitis and adenitis
* Bacterial/Fungal infection
GRADE II LYMPHEDEMA LEFT LEG
WITH ACUTE LYMPHANGITIS
Acute Filarial Lymphangitis
Acute Dermatolymphangioadenitis
Entry lesions
Acute attack
Post - Acute attack
GRADE II LYMPHEDEMA LEFT LEG
GRADE III LYMPHEDEMA BOTH LEGS
WITH SKIN PIGMENTATION
GRADE 1 LYMPHEDEMA LEFT LEG
Lymphatic filariasis17102023 for MBBS students.pptx
Leg
Breast
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Strategies for ELF
 Interruption of transmission of
filariasis by Annual MDA for 5
years or more to the population
except:
 children below 2 years
 pregnant women
 seriously ill persons
 (DEC + Albendazole )
 Morbidity Management
 Home based management of
lymphoedema cases
 up-scaling of hydrocele operations
in the identified CHCs / District
hospitals/ medical colleges.
How does MDA work ?
Elimination of Lymphatic Filariasis
MDA Success depends on
• High coverage (>65% of
total population)
• Sustained coverage over
5-7 years
1
•Pre MDA
2
•During MDA
3
•Post MDA
Activities for MDA
Doses of Albendazole and DEC
according to age
Medicine Eligible population Dose
Albedazole-400
mg
All persons above 2 years
of age
1*400 mg
DEC (100 mg) 2-5 years of age 1*100 mg
DEC (200 mg) 6-15 years of age 2*100 mg
DEC (100 mg) Above 15 years of age 3*100 mg
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Advances in mass treatment
• TRIPLE DRUG combination
therapy
• Small scale clinical trials &
safety studies completed
• More effective than two-drug
therapy, very promising
• Recently recommended by
WHO for MDA
• Rolled out in selected districts
in India
DEC
+
Ivermectin
(12 mg adult dose)
+
Albendazole
Inaugural Ceremony
DC Mr. Jatashankar Chaudhary inaugurated the Ceremony by
consuming Anti Filarial Drug
45
Bhag Filaria Bhag- A School programme launched by the DC, Simdega in all Govt. &
Pvt. Schools (approx. 377 in nos.) in mission mode for awareness regarding MDA.
Filaria Rally & Media Sensitization Workshop 46
IEC Material
Hoarding Banner Poster
Wall Painting Broshure Handbill News Paper Advt.
47
Flag hoisting of Miking Van by MLA
Sensitization of local leaders by DC Nukkar Natak in Village & Haat
Awareness through Jhanki
IEC Activities
48
Local Dose Pole Prepared by District
Drug Compliance in School
Local Leaders Meeting Field Monitoring by State Team
49
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Morbidity Management
Alleviation of Suffering
&
Disability Prevention
MORBIDITY MANAGEMENT
Scope:
a. Lymphoedema / Elephantiasis
b. Hydrocele & other Genitourinary manifestations
c. Acute ADL episodes
Strategy:
1. Treatment & Prevention of acute episodes
2. Management of Lymphoedema
3. Appropriate surgery
3. Prevention of disease progression
• Twice-daily washing of the affected parts
with soap and water
• Raising the affected limb at night
• Regularly exercising the affected limb to
promote lymph flow
• Keeping the nails clean
• Wearing shoes
• Use of antiseptic or antibiotic creams to treat
small wounds or abrasions.
Management Regimens
LOCAL HYGIENE
Care of affected limb: Wash with
soap & water. If infected wounds or
entry lesions in deep folds, use anti
septic
Keep skin dry & clean
Care of nails
Entry lesions
Topical antifungals
Topical antibiotics
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Lymphatic filariasis17102023 for MBBS students.pptx
Hydrocele surgery
• Hydrocelectomy is usually done
in CHCs, district hospitals or
medical colleges free of cost.
• Programme emphasises to
intensify the hydrocele
operations in camp mode for
more operations
• The incentives to promote such
activities are provided @ Rs.750
per case
• Some states pay more out of
state resources but it varies
from state to state
THANK YOU

More Related Content

PPTX
EPIDEMIOLOGY OF FILARIASIS
PPTX
FILARIASIS CONTROL PROGRAMME-INDIA
PPTX
EPIDEMIOLOGY OF FILARIASIS
PPTX
national filariasis control programme ppt
PPTX
Lymphatic Filariasis - Community Medicine
PDF
Lymphatic Filariasis .ppt
PDF
Filariasis.pdfbbnnnvvbbbbbbbhhhhgdddhjhfhju
PPTX
National filarial control programme
EPIDEMIOLOGY OF FILARIASIS
FILARIASIS CONTROL PROGRAMME-INDIA
EPIDEMIOLOGY OF FILARIASIS
national filariasis control programme ppt
Lymphatic Filariasis - Community Medicine
Lymphatic Filariasis .ppt
Filariasis.pdfbbnnnvvbbbbbbbhhhhgdddhjhfhju
National filarial control programme

Similar to Lymphatic filariasis17102023 for MBBS students.pptx (20)

PPTX
Filariasis_One Day_Modified powerpoint presentation
PPTX
LYMPHATIC FILARIASIS Community medicine.pptx
PPT
Filariasis
PPTX
LF, Lymphatic Filariasis, PSM,COMMUNITY MEDICINE,DR NARENDRA KUMAR YADAV
PPTX
filariasisssssssssssssssssssssssssss.pptx
PPTX
Lymphatic Filariasis.pptx
PPTX
Community Medicine: Filariasis in Nepal
PPTX
Filariasis
PDF
Filariasis
PPTX
Lymphatic Filariasis: Global and National Perspective.pptx
PPTX
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
PDF
LFMMDP_module1_ENglish njjsdabfkjbkj.pdf
PPTX
filariases.pptx
PPTX
Module 1 Presentation A - WHO MMDP Workshop_GPELF background_10May22.pptx
PPTX
FILARIASIS CASE STUDY NURSING STUDENT.PPTX
PPT
FILARIASIS.ppt
PPT
Lymphatic Filariasis
PPTX
20161022 filariasis
PPTX
Epidemiology, control and management of FILARIASIS
Filariasis_One Day_Modified powerpoint presentation
LYMPHATIC FILARIASIS Community medicine.pptx
Filariasis
LF, Lymphatic Filariasis, PSM,COMMUNITY MEDICINE,DR NARENDRA KUMAR YADAV
filariasisssssssssssssssssssssssssss.pptx
Lymphatic Filariasis.pptx
Community Medicine: Filariasis in Nepal
Filariasis
Filariasis
Lymphatic Filariasis: Global and National Perspective.pptx
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
LFMMDP_module1_ENglish njjsdabfkjbkj.pdf
filariases.pptx
Module 1 Presentation A - WHO MMDP Workshop_GPELF background_10May22.pptx
FILARIASIS CASE STUDY NURSING STUDENT.PPTX
FILARIASIS.ppt
Lymphatic Filariasis
20161022 filariasis
Epidemiology, control and management of FILARIASIS

Recently uploaded (20)

PDF
Nurlina - Urban Planner Portfolio (english ver)
PDF
The TKT Course. Modules 1, 2, 3.for self study
PDF
Everyday Spelling and Grammar by Kathi Wyldeck
PPTX
Neurological complocations of systemic disease
PPTX
Reproductive system-Human anatomy and physiology
PPTX
Integrated Management of Neonatal and Childhood Illnesses (IMNCI) – Unit IV |...
PDF
Physical education and sports and CWSN notes
PDF
fundamentals-of-heat-and-mass-transfer-6th-edition_incropera.pdf
PPTX
ACFE CERTIFICATION TRAINING ON LAW.pptx
PPTX
Neurology of Systemic disease all systems
PPTX
Diploma pharmaceutics notes..helps diploma students
PDF
faiz-khans about Radiotherapy Physics-02.pdf
PDF
Diabetes Mellitus , types , clinical picture, investigation and managment
PDF
African Communication Research: A review
PPTX
pharmaceutics-1unit-1-221214121936-550b56aa.pptx
PPTX
IT infrastructure and emerging technologies
PDF
Solved Past paper of Pediatric Health Nursing PHN BS Nursing 5th Semester
PPTX
BSCE 2 NIGHT (CHAPTER 2) just cases.pptx
PDF
Health aspects of bilberry: A review on its general benefits
PDF
Compact First Student's Book Cambridge Official
Nurlina - Urban Planner Portfolio (english ver)
The TKT Course. Modules 1, 2, 3.for self study
Everyday Spelling and Grammar by Kathi Wyldeck
Neurological complocations of systemic disease
Reproductive system-Human anatomy and physiology
Integrated Management of Neonatal and Childhood Illnesses (IMNCI) – Unit IV |...
Physical education and sports and CWSN notes
fundamentals-of-heat-and-mass-transfer-6th-edition_incropera.pdf
ACFE CERTIFICATION TRAINING ON LAW.pptx
Neurology of Systemic disease all systems
Diploma pharmaceutics notes..helps diploma students
faiz-khans about Radiotherapy Physics-02.pdf
Diabetes Mellitus , types , clinical picture, investigation and managment
African Communication Research: A review
pharmaceutics-1unit-1-221214121936-550b56aa.pptx
IT infrastructure and emerging technologies
Solved Past paper of Pediatric Health Nursing PHN BS Nursing 5th Semester
BSCE 2 NIGHT (CHAPTER 2) just cases.pptx
Health aspects of bilberry: A review on its general benefits
Compact First Student's Book Cambridge Official

Lymphatic filariasis17102023 for MBBS students.pptx

  • 1. Lymphatic filariasis Dr. Suman Saurabh Associate Professor, Department of Community and Family Medicine
  • 4. Organisms and vectors Disease Causative organism Vector Malaria Protozoal parasite: P. vivax P. falciparum Mosquito anopheles Lymphatic filariasis Nematode: Wuchereria bancrofti Brugia malayi Mosquito Culex species (mainly Culex quinquefasciatus) Kala-azar Protozoal parasite: Leishmania donovani Sandfly (Phlebotomus Argentipes) Dengue Dengue virus (4 serotypes) Aedes aegypti mosquito Chikungunya Chikungunya virus Aedes aegypti mosquito Japanese encephalitis JE virus Culex species (mainly Culex tritaeniorhynchus)
  • 5. Malaria An. culicifacies, An. fluviatilis, An. minimus An. sundaicus, An. stephensi, An. dirus Dengue Ae. Aegypti, Ae. Albopictus Filariasis Cx. quinquefasciatus, Ma. annulifera and uniformis Japanese Encephalistis Cx. vishnui, Cx. tritaeniorhyncus etc. Kala azar--- Sand fly Disease Vector species in India Malaria ,Kala-azar and Filaria in Elimination mode
  • 6. National programme • The malaria control programme • Lymphatic Filariasis • Kala-azar • Japanese Encephalitis • Dengue • Chikungunya Integrated under National Vector Borne Disease Control Programme (NVBDCP) in Year 2002
  • 8. GLOBAL BURDEN OF LF • Population at risk : 1.23 Billion • No. of countries: 73 • Hydrocele : 25 Million • Lymphoedema : 15 Million
  • 10. NATIONAL BURDEN OF LF RAJASTHAN ORISSA GUJARAT MAHARASHTRA MADHYA PRADESH BIHAR KARNATAKA UTTAR PRADESH JAMMU & KASHMIR ASSAM TAMIL NADU TELANGANA CHHATTISGARH ANDHRA PRADESH PUNJAB JHARKHAND WEST BENGAL ARUNACHAL PR. HARYANA KERALA UTTARAKHAND HIMACHAL PRADESH MANIPUR MIZORAM MEGHALAYA NAGALAND SIKKIM GOA A&N ISLANDS D&N HAVELI PONDICHERRY LAKSHADWEEP TRIPURA DELHI CHANDIGARH DAMAN & DIU N E W S Endemic Non-Endemic Uncertain 21 states/UTs 257 districts 650 millions Hydrocele- 0.38 million Lymphoedema-0.84 million
  • 11. Economic Impact of LF • Globally >2 billion USD lost per year • Approx. 5 million DALYs lost annually • Direct costs – ‘Out-of-pocket’ payments for care – Costs to health system • Indirect costs – Lost productivity (↓30%) – Social and Psychological impact
  • 12. LIFE CYCLE OF FILARIAL PARASITE
  • 13. Video courtesy District vector control unit, Kerala
  • 14. Photo courtesy District vector control unit, Kerala
  • 15. The parasite • Three parasites causing human filariasis: W. bancrofti B. malayi B. timori • In India W. bancrofti and B.malayi • W. bancrofti – Vector: Culex quinquefasciatus (Breeds in polluted water) - Contributes 99.4% LF in India - Distribution both urban & rural • B.malayi - Seven states – Kerala, Orissa, Tamil Nadu ( Rural areas) AP, MP, Assam, West Bengal in pockets - Vector: Mansonia sp (Breeding associated with aquatic plants, viz Pistia)
  • 16. Filariasis vectors and their breeding spots Culex quinquefasciatus Mansonia annulifera Culex quinquefasciatus breeding spot Mansonia breeding places in Pistia plants
  • 17. Natural History of Lymphatic Filariasis Un infected individuals Disease free microfilarial carrier state Acute disease manifestation Patients with chronic pathology
  • 18. Lymphatic Filariasis Disease Manifestation Asymptomatic Symptomatic Acute • Adenolymphangitis • Acute epididymo- orchitis • funiculitis Chronic • Lymphoedema • Hydrocele • Elephantiasis • Chyluria
  • 19. Clinical spectrum • Man-Natural host. • All ages and genders- susceptible to infection - Youngest age recorded with infection – 6 months - Peak age of infection= 20 – 25 yrs. • While infection occurs in child hood diseases manifests later. • Disease spectrum: – Endemic normal – Asymptomatic micro filarimia ● Sub clinical lymphatic pathology . – Acute manifestation – Chronic disease – Occult clinical manifestation » Tropical pulmonary Eosinophilia
  • 20. Acute manifestation Acute Filarial lymphangitis (AFL): • Characterised by presence of dilated, inflammed and thickened lymphatic vessels associated with erythema, oedema,tenderness and pain. • Cause: Parturition of adult, release of diffusible toxin or death of adult worm. Dermato lymphangio adenitis (ADLA) * Entry lesion-Reticular lymphangitis and adenitis * Bacterial/Fungal infection GRADE II LYMPHEDEMA LEFT LEG WITH ACUTE LYMPHANGITIS
  • 25. Post - Acute attack
  • 26. GRADE II LYMPHEDEMA LEFT LEG GRADE III LYMPHEDEMA BOTH LEGS WITH SKIN PIGMENTATION GRADE 1 LYMPHEDEMA LEFT LEG
  • 28. Leg
  • 32. Strategies for ELF  Interruption of transmission of filariasis by Annual MDA for 5 years or more to the population except:  children below 2 years  pregnant women  seriously ill persons  (DEC + Albendazole )  Morbidity Management  Home based management of lymphoedema cases  up-scaling of hydrocele operations in the identified CHCs / District hospitals/ medical colleges.
  • 33. How does MDA work ?
  • 34. Elimination of Lymphatic Filariasis MDA Success depends on • High coverage (>65% of total population) • Sustained coverage over 5-7 years
  • 35. 1 •Pre MDA 2 •During MDA 3 •Post MDA Activities for MDA
  • 36. Doses of Albendazole and DEC according to age Medicine Eligible population Dose Albedazole-400 mg All persons above 2 years of age 1*400 mg DEC (100 mg) 2-5 years of age 1*100 mg DEC (200 mg) 6-15 years of age 2*100 mg DEC (100 mg) Above 15 years of age 3*100 mg
  • 40. Advances in mass treatment • TRIPLE DRUG combination therapy • Small scale clinical trials & safety studies completed • More effective than two-drug therapy, very promising • Recently recommended by WHO for MDA • Rolled out in selected districts in India DEC + Ivermectin (12 mg adult dose) + Albendazole
  • 41. Inaugural Ceremony DC Mr. Jatashankar Chaudhary inaugurated the Ceremony by consuming Anti Filarial Drug 45
  • 42. Bhag Filaria Bhag- A School programme launched by the DC, Simdega in all Govt. & Pvt. Schools (approx. 377 in nos.) in mission mode for awareness regarding MDA. Filaria Rally & Media Sensitization Workshop 46
  • 43. IEC Material Hoarding Banner Poster Wall Painting Broshure Handbill News Paper Advt. 47
  • 44. Flag hoisting of Miking Van by MLA Sensitization of local leaders by DC Nukkar Natak in Village & Haat Awareness through Jhanki IEC Activities 48
  • 45. Local Dose Pole Prepared by District Drug Compliance in School Local Leaders Meeting Field Monitoring by State Team 49
  • 49. Morbidity Management Alleviation of Suffering & Disability Prevention
  • 50. MORBIDITY MANAGEMENT Scope: a. Lymphoedema / Elephantiasis b. Hydrocele & other Genitourinary manifestations c. Acute ADL episodes Strategy: 1. Treatment & Prevention of acute episodes 2. Management of Lymphoedema 3. Appropriate surgery 3. Prevention of disease progression
  • 51. • Twice-daily washing of the affected parts with soap and water • Raising the affected limb at night • Regularly exercising the affected limb to promote lymph flow • Keeping the nails clean • Wearing shoes • Use of antiseptic or antibiotic creams to treat small wounds or abrasions. Management Regimens
  • 52. LOCAL HYGIENE Care of affected limb: Wash with soap & water. If infected wounds or entry lesions in deep folds, use anti septic Keep skin dry & clean Care of nails Entry lesions Topical antifungals Topical antibiotics
  • 62. Hydrocele surgery • Hydrocelectomy is usually done in CHCs, district hospitals or medical colleges free of cost. • Programme emphasises to intensify the hydrocele operations in camp mode for more operations • The incentives to promote such activities are provided @ Rs.750 per case • Some states pay more out of state resources but it varies from state to state

Editor's Notes

  • #10: The learning objectives for this session are the following: To describe the difference between probability and non-probability sampling To list the advantages & disadvantages of various types of probability and non-probability samples, and To differentiate between sampling error and bias
  • #26: Acute attack This slide illustrates the limb during an acute attack. Note the swelling, redness and the shiny skin. In the second picture you can clearly see the entry lesions that occurred during the acute attack.
  • #27: Post - Acute attack This clinical photograph illustrates the events that are seen after the acute attack. These include blistering of the skin and the separation of the dead skin as seen over the sole.